Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population.
Valeria DipasqualeAngela AlibrandiSalvatore PellegrinoVincenzo RamistellaClaudio RomanoPublished in: Expert review of clinical immunology (2023)
This study discovered some predictors for IFX-BioS TLs in IBD children. Knowledge of predictive factors could help physicians choose the best dosing regimen.
Keyphrases